Your browser doesn't support javascript.
loading
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma.
Thomas, Anne; Virdee, Pradeep S; Eatock, Martin; Lord, Simon R; Falk, Stephen; Anthoney, D Alan; Turkington, Richard C; Goff, Matthew; Elhussein, Leena; Collins, Linda; Love, Sharon; Moschandreas, Joanna; Middleton, Mark R.
Afiliación
  • Thomas A; University of Leicester, Leicester, UK. Electronic address: at107@le.ac.uk.
  • Virdee PS; Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
  • Eatock M; Belfast City Hospital, Belfast, UK.
  • Lord SR; University of Oxford, Oxford, UK.
  • Falk S; Bristol Haematology & Oncology Centre, Bristol, UK.
  • Anthoney DA; St. James University Hospital, Leeds, UK.
  • Turkington RC; Centre for Cancer Research and Cell Biology, Queens University Belfast, Belfast, UK.
  • Goff M; Oncology Clinical Trials Office, University of Oxford, Oxford, UK.
  • Elhussein L; Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
  • Collins L; Oncology Clinical Trials Office, University of Oxford, Oxford, UK.
  • Love S; Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
  • Moschandreas J; Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
  • Middleton MR; University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, UK.
Eur J Cancer ; 124: 131-141, 2020 01.
Article en En | MEDLINE | ID: mdl-31765988

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oxaloacetatos / Quinazolinas / Neoplasias Gástricas / Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Receptor ErbB-3 / Capecitabina Tipo de estudio: Clinical_trials Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oxaloacetatos / Quinazolinas / Neoplasias Gástricas / Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Receptor ErbB-3 / Capecitabina Tipo de estudio: Clinical_trials Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article